Cargando…

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy

Diabetic retinopathy (DR) is a microvascular disease caused by poorly controlled blood glucose, and it is a leading cause of vision loss in people with diabetes. In this review we discuss the current management of DR with particular focus on the use of intraocular anti-vascular endothelial growth fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bahr, Tyler A., Bakri, Sophie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222751/ https://www.ncbi.nlm.nih.gov/pubmed/37240743 http://dx.doi.org/10.3390/life13051098

Ejemplares similares

Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative Retinopathy
por: Vavuli, Satu, et al.
Publicado: (2016)

Therapeutic Effect of Abelmoschus manihot on Type 2 Diabetic Nonproliferative Retinopathy and the Involvement of VEGF
por: Zhao, Yue, et al.
Publicado: (2020)

Using Ultrawide Field-Directed Optical Coherence Tomography for Differentiating Nonproliferative and Proliferative Diabetic Retinopathy
por: Ashraf, Mohamed, et al.
Publicado: (2023)

Determining Risk Factors That Affect Progression in Patients with Nonproliferative Diabetic Retinopathy
por: Chen, Dalbert J., et al.
Publicado: (2021)

Ocular Rigidity and Outflow Facility in Nonproliferative Diabetic Retinopathy
por: Panagiotoglou, Theonitsa, et al.
Publicado: (2015)

Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy
por: Takayama, Kei, et al.
Publicado: (2021)

Different Risk Profiles for Progression of Nonproliferative Diabetic Retinopathy: A 2-Year Study
por: Marques, Inês P., et al.
Publicado: (2022)

Serum TNF-Alpha Level Predicts Nonproliferative Diabetic Retinopathy in Children
por: Zorena, Katarzyna, et al.
Publicado: (2007)

Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study
por: Smolek, Michael K, et al.
Publicado: (2013)

Optical Coherence Tomography Angiography Contributions in Classification of Nonproliferative Diabetic Retinopathy
por: Kasumovic, Armin, et al.
Publicado: (2020)

The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy
por: Kuiper, Esther J., et al.
Publicado: (2008)

Decreased Retinal Thickness in Type 1 Diabetic Children with Signs of Nonproliferative Diabetic Retinopathy
por: Ruiz-Ocaña, P., et al.
Publicado: (2018)

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
por: Zhao, Yue, et al.
Publicado: (2018)

The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment
por: Tremolada, Gemma, et al.
Publicado: (2012)

Combined Tractional and Rhegmatogenous Retinal Detachment in Proliferative Diabetic Retinopathy in the Anti-VEGF Era
por: Hsu, Ya-Jui, et al.
Publicado: (2014)

Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
por: Perais, Jennifer, et al.
Publicado: (2023)

Vitreous and Plasma VEGF Levels as Predictive Factors in the Progression of Proliferative Diabetic Retinopathy after Vitrectomy
por: Wang, Jiaxing, et al.
Publicado: (2014)

A Paradigm Shift in the Management Approaches of Proliferative Diabetic Retinopathy: Role of Anti-VEGF Therapy
por: Raman, Rajiv, et al.
Publicado: (2022)

Assessment of optical coherence tomography angiography and multifocal electroretinography in eyes with and without nonproliferative diabetic retinopathy
por: Srinivasan, Sangeetha, et al.
Publicado: (2021)

Diabetic Retinopathy and VEGF
por: Gupta, N, et al.
Publicado: (2013)

Impact of Intravitreal Anti-VEGF Therapy on Microperimetry of the Retinal Nonperfusion Areas of Patients with Proliferative Diabetic Retinopathy
por: Parravano, Mariacristina, et al.
Publicado: (2022)

Nonproliferative and Proliferative Lesions of the Rat and Mouse Endocrine System
por: Brändli-Baiocco, Annamaria, et al.
Publicado: (2018)

Superficial capillary perfusion on optical coherence tomography angiography differentiates moderate and severe nonproliferative diabetic retinopathy
por: Ong, Janice X., et al.
Publicado: (2020)

Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy
por: Tsubota, Kinya, et al.
Publicado: (2019)

Heritability of Proliferative Diabetic Retinopathy
por: Hietala, Kustaa, et al.
Publicado: (2008)

Proliferative diabetic retinopathy in acromegaly
por: Malhotra, Chintan
Publicado: (2010)

Preventing sight loss from proliferative diabetic retinopathy
Publicado: (2015)

Hyperreflective Intraretinal Spots in Diabetics without and with Nonproliferative Diabetic Retinopathy: An In Vivo Study Using Spectral Domain OCT
por: Vujosevic, Stela, et al.
Publicado: (2013)

Associations between Macular OCT Angiography and Nonproliferative Diabetic Retinopathy in Young Patients with Type 1 Diabetes Mellitus
por: Veiby, Nina C. B. B., et al.
Publicado: (2020)

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
por: Wang, Tianqin, et al.
Publicado: (2021)

Pars Plana Vitrectomy Reoperations for Complications of Proliferative Diabetic Retinopathy
por: Al-khersan, Hasenin, et al.
Publicado: (2020)

Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus
por: Choudhuri, Subhadip, et al.
Publicado: (2013)

Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients
por: Izuta, Hiroshi, et al.
Publicado: (2009)

VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients
por: Rezzola, Sara, et al.
Publicado: (2021)

Comparative Analysis of the Effects of the Anti-VEGF Drug and Glucocorticoid by Injection before the End of Vitrectomy for Proliferative Diabetic Retinopathy
por: Zhao, Haijin, et al.
Publicado: (2021)

Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy
por: Nguyen, Quan Dong, et al.
Publicado: (2023)

Combined Use of Anti-VEGF Drugs Before and During Pars Plana Vitrectomy for Severe Proliferative Diabetic Retinopathy
por: Sun, Xincheng, et al.
Publicado: (2023)

Venous beading in two or more quadrants might not be a sensitive grading criterion for severe nonproliferative diabetic retinopathy
por: Chen, Ling, et al.
Publicado: (2018)

Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial
por: Brown, David M., et al.
Publicado: (2021)

Nonproliferative and Proliferative Lesions of the Rat and Mouse Female Reproductive System
por: Dixon, Darlene, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qn6sbcj817qk6k1i7tlctfs8va